Correlation Analysis between Single-Nucleotide Polymorphism and Expression Arrays in Gliomas Identifies Potentially Relevant Target Genes
- 12 February 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (4) , 1596-1603
Abstract
Primary brain tumors are a major cause of cancer mortality in the United States. Therapy for gliomas, the most common type of primary brain tumors, remains suboptimal. The development of improved therapeutics will require greater knowledge of the biology of gliomas at both the genomic and transcriptional levels. We have previously reported whole genome profiling of chromosome copy number alterations (CNA) in gliomas, and now present our findings on how those changes may affect transcription of genes that may be involved in tumor induction and progression. By calculating correlation values of mRNA expression versus DNA copy number average in a moving window around a given RNA probe set, biologically relevant information can be gained that is obscured by the analysis of a single data type. Correlation coefficients ranged from −0.6 to 0.7, highly significant when compared with previous studies. Most correlated genes are located on chromosomes 1, 7, 9, 10, 13, 14, 19, 20, and 22, chromosomes known to have genomic alterations in gliomas. Additionally, we were able to identify CNAs whose gene expression correlation suggests possible epigenetic regulation. This analysis revealed a number of interesting candidates such as CXCL12, PTER, and LRRN6C, among others. The results have been verified using real-time PCR and methylation sequencing assays. These data will further help differentiate genes involved in the induction and/or maintenance of the tumorigenic process from those that are mere passenger mutations, thereby enriching for a population of potentially new therapeutic molecular targets. [Cancer Res 2009;69(4):1596–603]Keywords
All Related Versions
This publication has 18 references indexed in Scilit:
- Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death through c-MYC, Nuclear Factor-κB, and Glucose RegulationCancer Research, 2008
- Chromosomal aberrations and gene expression profiles in non-small cell lung cancerLung Cancer, 2007
- High-resolution Global Genomic Survey of 178 Gliomas Reveals Novel Regions of Copy Number Alteration and Allelic ImbalancesCancer Research, 2006
- Transcriptional silencing of EphB6 receptor tyrosine kinase in invasive breast carcinoma cells and detection of methylated promoter by methylation specific PCRBiochemical and Biophysical Research Communications, 2006
- An interactive power analysis tool for microarray hypothesis testing and generationBioinformatics, 2006
- HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiformeJournal of Neuro-Oncology, 2005
- Favorable Neuroblastoma Genes and Molecular Therapeutics of NeuroblastomaClinical Cancer Research, 2004
- Gene-Ontology analysis reveals association of tissue-specific 5' CpG-island genes with development and embryogenesisHuman Molecular Genetics, 2004
- Loss of EphB6 expression in metastatic melanomaInternational Journal of Oncology, 2003
- High density synthetic oligonucleotide arraysNature Genetics, 1999